A Phase 1 Study of BMS-986406 as Monotherapy and in Combination in Advanced Tumors
CA111-001
Phase 1 other active
Quick answer
A Phase 1 Study of BMS-986406 as Monotherapy and in Combination in Advanced Tumors for Advanced Malignant Tumors is a Phase 1 program (other) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Advanced Malignant Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active